. . . . . . . . . . . . . . "a(SCHEM:Hirudin) =| cat(p(HGNC:F2))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "The DTI include Hirudin, Bivalirudin, and a second generation of agents, called active site inhibitors. Melagatran, together with its oral prodrug (Ximelagatran) is the most extensively investigated of this last group of drugs." . . "Selventa" . . . . "2014-07-03T14:30:22.502+02:00"^^ . . .